Healthcare expenditure on Over-The-Counter (OTC) medicines in France is projected to decrease steadily from 2.63 billion Euros in 2024 to 2.47 billion Euros by 2028. This forecasted drop represents a year-on-year reduction, averaging around 1.5% each year. Comparing to the figures from 2023, typical trends suggest a notable contraction in spending.
Key forecasted trends from 2024 to 2028 are as follows:
• 2024: +2.63 Billion Euros (base year)
• 2025: -1.5% to 2.59 Billion Euros
• 2026: -1.5% to 2.55 Billion Euros
• 2027: -1.6% to 2.51 Billion Euros
• 2028: -1.6% to 2.47 Billion Euros
Future trends to watch for include potential policy changes affecting healthcare budgets, a possible shift towards prescription medicines, and innovations in alternative treatment options. Additionally, the impact of demographic changes, particularly an aging population, and consumer behavior shifts toward online medicine purchases will be crucial factors to monitor.
Latest reports
US Erectile Dysfunction Market Report- Q1 2025
The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...
South Korea Erectile Dysfunction Market Report- Q4 2024
The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...
Spain Erectile Dysfunction Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...
